The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1
Gemcitabine is used to treat several cancers including lung cancer. However, tumor cells often escape gemcitabine-induced cell death via various mechanisms, which include modulating bcl-2 family members and NF-κB activation. We previously reported that the C-terminal region of Bfl-1 fused with GFP (...
Main Authors: | Kim, Min-Kyoung, Jeon, Yoon-Kyung, Woo, Jong-Kyu, Choi, Yun, Choi, Dae-Han, Kim, Yeul-Hong, Kim, Chul-Woo |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166274/ |
Similar Items
-
A1/Bfl-1 in leukocyte development and cell death
by: Ottina, Eleonora, et al.
Published: (2012) -
Bfl-1 gene expression in breast cancer: its relationship with other prognostic factors.
by: Yoon, Ho-Sung, et al.
Published: (2003) -
Anti-Apoptotic Bfl-1 Is the Major Effector in Activation-Induced Human Mast Cell Survival
by: Ekoff, Maria, et al.
Published: (2012) -
Ds tagging of BRANCHED FLORETLESS 1 (BFL1) that mediates the transition from spikelet to floret meristem in rice (Oryza sativa L)
by: Zhu, Qian-Hao, et al.
Published: (2003) -
µ-Calpain Conversion of Antiapoptotic Bfl-1 (BCL2A1) into a Prodeath Factor Reveals Two Distinct alpha-Helices Inducing Mitochondria-Mediated Apoptosis
by: Valero, Juan García, et al.
Published: (2012)